The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1007/s10072-018-3580-2
|View full text |Cite
|
Sign up to set email alerts
|

Atypical clinical manifestations of Miller Fisher syndrome

Abstract: Miller Fisher syndrome (MFS) is characterized by a clinical triad of ophthalmoplegia, ataxia, and areflexia, and is closely associated with serum anti-GQ1b antibody. Although the clinical triad is the cardinal diagnostic clue, a variety of other symptoms and signs beyond the triad have been reported. To elucidate the frequency and characteristics of atypical clinical manifestations of MFS, we recruited 38 patients with MFS and evaluated the symptoms or signs beyond the classic triad. Eleven (29%) of 38 patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
18
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 20 publications
1
18
0
2
Order By: Relevance
“…Cranial mononeuropathy with brachial diparesis, albumincytologic dissociation, and areflexia in the second case can suggest an atypical MFS overlap [17].…”
Section: Discussionmentioning
confidence: 85%
“…Cranial mononeuropathy with brachial diparesis, albumincytologic dissociation, and areflexia in the second case can suggest an atypical MFS overlap [17].…”
Section: Discussionmentioning
confidence: 85%
“…In this case, enhancement along the neural sheath of the oculomotor nerve was observed on the orbital MRI, as well as the fast recovery of the patient’s symptoms, supporting the theory of demyelination. Moreover, the atypical presentation of Fisher syndrome could be considered as one of possible diagnoses of this case, considering various clinical manifestations and the ganglioside antibody profile of Fisher syndrome [15, 16]. Although CSF profile and negative anti-GQ1b antibody were not compatible with Fisher syndrome, the self-limiting disease course of our case and previous reports of GBS and Fisher syndrome after vaccination were suggestive of a diagnosis of Fisher syndrome in this case.…”
Section: Discussion/conclusionmentioning
confidence: 48%
“…In other recent study, six of the 38 patients (16%) with MFS experienced headache during the acute phase. Three of them complained of pain with over moderate (over 5 score by Wong-Baker FACES Pain Rating Scale), and NSAIDs was not effective in all patients [5].…”
Section: Discussionmentioning
confidence: 88%